Live Breaking News & Updates on India Pharma Companies
Stay updated with breaking news from India pharma companies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Indian drugmakers are developing their versions of Novo Nordisk s weight-loss treatment, Wegovy, aiming to capitalize on the growing weight-loss market, expected to reach $100 billion a year by the end of the decade. Companies like Sun Pharma, Cipla, Dr Reddy s, and Lupin are working on Wegovy alternatives as Novo Nordisk struggles to meet global demand. ....
Dr Reddy’s Laboratories (DRL) has applied for emergency use authorisation with the Indian drug regulator for Sputnik V vaccine. Earlier, DRL had indicated that it aimed to launch the vaccine in March itself if it gets the regulator s nod. It has lined up 250 million doses of the vaccine for Indian citizens (from manufacturing partners) over the next 12 months. The human adenoviral vector (flu virus)-based vaccine candidate is developed by Gamaleya National Research Institute of Epidemiology and Microbiology in Russia and was registered in that country in August last year. DRL will present the safety profile of the phase 2 clinical study and the interim data of the phase 3 study which is expected to be completed by February 21, the company said. ....
Updated Jan 07, 2021 | 13:11 IST India now has 17 billionaire promoters in the healthcare and pharma space, up from 10 last year who cumulatively held Rs 4.35 lakh crore or $60 billion at the end of December 2020 Big billions! India minted 7 super-rich promoters (not techpreneurs) in pandemic year 2020  |  Photo Credit: Twitter Key Highlights India saw the emergence of 7 new billionaire promoters in the healthcare and pharma space alone in calendar year 2020 Total wealth of these 17 billionaires surged by 61% or Rs 1.65 lk cr or $23 bn in 2020 on yearly basis Mumbai: The year 2020 was indeed unprecedented in terms of sheer destruction caused due the pandemic and unprecedented loss of life. While doctors and healthcare workers were at the frontline battling the Covid-19 outbreak, the promoters in the pharmaceutical and healthcare space were being rewarded by investors and markets. ....